CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China
CBC Group and Mubadala acquire UCB's mature neurology and allergy business in China for US$680 million. New company is named NeuroGen Pharma, led by an experienced management team with a strong track record in the biopharma industry. Strategic...
MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China
SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for injection transitioning to oral Contezolid tablets for...
TRACCOM INC. (Pink Open Market Symbol: TRCC) COMPLETES ACQUISITION OF VULCAIN, INC.
SANTA BARBARA, Calif., Nov. 26, 2024 /PRNewswire/ -- Traccom Inc. (Pink Open Market Symbol: TRCC) is pleased to announce that on November 13, 2024, it acquired all of the capital stock of Vulcain, Inc. ("Vulcain"). As a result of the acquisition,...